Showing 461 - 480 results of 103,947 for search '(( a fold decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.52s Refine Results
  1. 461
  2. 462

    Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

    Published 2013
    “…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”
  3. 463
  4. 464
  5. 465
  6. 466
  7. 467
  8. 468
  9. 469
  10. 470

    Talin concentration at muscle attachment sites increases 5-fold during attachment maturation. by Sandra B. Lemke (6519788)

    Published 2019
    “…Note that the concentration increases about 2-fold from 20 h to 24 h APF and 5-fold to 30 h APF. …”
  11. 471
  12. 472
  13. 473
  14. 474
  15. 475

    Identification of mutations that impair global folding. by Radhika Gopal (4692103)

    Published 2017
    “…Only one mutation T329A (red dot) resulted in markedly decreased V5 expression. …”
  16. 476

    Plasmids and oligos used in this study. by Pétra Vande Zande (17628246)

    Published 2024
    “…The combination of the chromosome 4 CNV and <i>KSR1</i> LOH results in a >500-fold decrease in azole susceptibility relative to the progenitor, illustrating a compelling example of rapid, yet step-wise, interplay between CNV and LOH in drug resistance evolution.…”
  17. 477

    Strains used in this study. by Pétra Vande Zande (17628246)

    Published 2024
    “…The combination of the chromosome 4 CNV and <i>KSR1</i> LOH results in a >500-fold decrease in azole susceptibility relative to the progenitor, illustrating a compelling example of rapid, yet step-wise, interplay between CNV and LOH in drug resistance evolution.…”
  18. 478

    Folding kinetics of CFSE using Treekin. by Vaitea Opuu (4966111)

    Published 2022
    “…<p>A) Barrier tree of the CFSE. From a set of 1.5 × 10<sup>6</sup> sub-optimal structures, 40 local minima were found, connected through saddle points. …”
  19. 479
  20. 480